Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells
Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells
复制标题
Adenanthin 靶向过氧化还原蛋白 I 和 II 诱导白血病细胞分化
DOI:
10.1038/nchembio.935
复制
发表时间:
2012-05-01
影响因子:
14.8
通讯作者:
Chen, Guo-Qiang
中科院分区:
文献类型:
--
作者:
Liu, Chuan-Xu;Yin, Qian-Qian;Chen, Guo-Qiang
Peroxiredoxins (Prxs) are potential therapeutic targets for major diseases such as cancers. However, isotype-specific inhibitors remain to be developed. We report that adenanthin, a diterpenoid isolated from the leaves of Rabdosia adenantha, induces differentiation of acute promyelocytic leukemia (APL) cells. We show that adenanthin directly targets the conserved resolving cysteines of Prx I and Prx II and inhibits their peroxidase activities. Consequently, cellular H2O2 is elevated, leading to the activation of extracellular signal-regulated kinases and increased transcription of CCAAT/enhancer-binding protein beta, which contributes to adenanthin-induced differentiation. Adenanthin induces APL-like cell differentiation, represses tumor growth in vivo and prolongs the survival of mouse APL models that are sensitive and resistant to retinoic acid. Thus, adenanthin can serve as what is to our knowledge the first lead natural compound for the development of Prx I-and Prx II-targeted therapeutic agents, which may represent a promising approach to inducing differentiation of APL cells.